ACRS — Aclaris Therapeutics Share News
0.000.00%
Last trade - 00:00- $532.87m
- $441.32m
- $7.83m
Brief: Aclaris Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. RESEARCH ROUNDUP-Microstrategy, Snowflake, Target
Aclaris soars after multiple brokerages upgrade ratings following key deal
U.S. RESEARCH ROUNDUP- Equifax, Microstrategy, Netflix
Aclaris rises after securing rights to two experimental immunology drugs
Brief: Aclaris Therapeutics Announces Exclusive, Global License Agreement With Biosion
Brief: Aclaris Therapeutics Q3 Revenue USD 4.346 Million
Aclaris Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview
Aclaris Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: Aclaris Therapeutics Q2 Revenue USD 2.766 Million
Aclaris Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview
Brief: Aclaris Therapeutics Announces Sale Of Olumiant Royalties And Milestones To Omers Life Sciences For Up To $31.5 Million
U.S. STOCKS ON THE MOVE-Sigma Lithium, U.S Gold , Ballard Power
U.S. STOCKS ON THE MOVE-New York Community Bancorp, TripAdvisor, Uber
Aclaris Therapeutics falls as Q1 revenue declines
Aclaris Therapeutics Inc reports results for the quarter ended in January - Earnings Summary
Brief: Aclaris Therapeutics Q1 Net Income USD -16.941 Million
Aclaris Therapeutics Inc expected to post a loss of 29 cents a share - Earnings Preview
Brief: Aclaris Therapeutics Q4 Net Income USD -1.491 Million